Eli Lilly on Thursday mentioned its next-generation drug cleared a vital late-stage trial in sufferers with obesity, delivering vital weight loss throughout doses. The outcomes convey Lilly one step nearer to submitting for approval of the weekly injection, referred to as retatrutide, which works in a different way from present pictures and tablets from each…
People stroll previous an indication for Novo Nordisk’s annual basic assembly on the entrance to the venue in Copenhagen, Denmark, March 26, 2026. Tom Little | Reuters Nordisk hiked its annual revenue steerage on Wednesday, because the drugmaker mentioned its Wegovy weight-loss capsule carried out higher than anticipated within the first three months of the…
David Ricks, chief government officer of Eli Lilly & Co., on the Semafor World Economy Summit in the course of the International Monetary Fund (IMF) and World Bank Spring conferences in Washington, DC, US, on Friday, April 17, 2026. Aaron Schwartz | Bloomberg | Getty Images Eli Lilly on Thursday reported first-quarter earnings and income…
The Eli Lilly emblem seems on the corporate’s workplace in San Diego, California, US, Nov. 21, 2025. Mike Blake | Reuters Eli Lilly will acquire biotech firm Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly pays $3.25 billion upfront, and the remaining funds are contingent upon medical, regulatory…
Nordisk has dropped its legal case against telehealth supplier Hims & Hers over patent infringement, after the 2 corporations agreed Hims would promote Novo’s branded medicines by its platform. “We have decided to drop the current court proceedings and, of course, we reserve to bring that back if need be, but I don’t foresee that…
The brand of pharmaceutical firm Novo Nordisk is displayed in entrance of its workplaces in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026. Tom Little | Reuters Nordisk on Tuesday stated it plans to slash the monthly list prices of its standard weight problems and diabetes medication within the US by up to 50% beginning in 2027,…
Nordisk stock fell 15% Monday after it stated its next-generation weight loss drug did not meet its key objective of exhibiting that it wasn’t inferior to Eli Lillys rival drug. The drug, CagriSema, failed to obtain its major endpoint of demonstrating non-inferiority on weight loss when put next to Eli Lilly’s rival drug tirzepatide after…
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026. Tom Little | Reuters Nordisk said Thursday it will take legal action against Hims & Hers after the telehealth provider announced it would launch a cheaper copycat version of Novo’s Wegovy weight loss pill….
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Wednesday. In addition to Disney’s Josh D’Amaro, there was another top dog announced yesterday: Penny the Doberman pinscher won best in show at the Westminster Kennel Club Dog Show. Stock futures are ticking higher this morning. The market is…
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, US, Sept. 23, 2025. Antranik Tavitian | Reuters Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soars. The pharmaceutical giant…
